InvestorsHub Logo
Followers 58
Posts 10189
Boards Moderated 1
Alias Born 09/21/2016

Re: IhidfromtheX post# 204890

Wednesday, 08/07/2019 9:26:55 AM

Wednesday, August 07, 2019 9:26:55 AM

Post# of 464406
Riddle :

Is Missling holding to his word of designed to fail and if the data supports failure, the study would be over not extended. He's thrifty!



That is my question also. None of us has posted that he is just confused or that there are results that are being WASHED for new PR claims, Like BIIB.

This is at least an interesting consideration. PM trials are bound to have serious questions about...NOW WHAT? In the dark days when everything failed this was not a problem when they just redefined success as w/current SOC.

An interesting question. Are we in the gray area between obvious failure and we don't know b/c we don't know what success really looks like? I am sure that at some point it will be unbearable and either a better definition for pass/fail will be written or it is obvious the patients have not improved yet. If a trial is continued b/c we think it is good, then what?

Since no one has ever demonstrated that CNS cellular Homeostasis has been restored we really are uncertain on how to define success. (see the famous guy who said the light has been turned on in a dark room). So I guess the old log books and ADL metrics apply. Cannot wait for some good solid ERP data.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News